Tuesday, May 30, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

MANHATTAN - BioScrip stock lost $210 million in market capitalization when its directors' misrepresentations were revealed in September, shareholders claim in a federal class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.